Anders Lindholm Sørensen

Statin treatment, oxidative stress and inflammation in a Danish population

Anders Lindholm Sørensen, Hans C. Hasselbalch, Claus Henrik Nielsen et al. · Redox Biology · 2018 · 112 citations · Full text

Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study

Anders Lindholm Sørensen, Stine Ulrik Mikkelsen, Trine Alma Knudsen et al. · Haematologica · 2019 · 103 citations · Full text

JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation

Julia Czech, Sabrina Cordua, Barbora Weinbergerová et al. · Leukemia · 2018 · 57 citations

Transcriptional Regulation, Increased Molecular Responses, Signal Transduction +13

Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis

Stine Ulrik Mikkelsen, Lasse Kjær, Mads Emil Bjørn et al. · Cancer Medicine · 2018 · 44 citations · Full text

Immunodeficiencies, Immunology, Pathology +19

Smoking is associated with increased risk of myeloproliferative neoplasms: A general population‐based cohort study

Kasper Mønsted Pedersen, Marie Bak, Anders Lindholm Sørensen et al. · Cancer Medicine · 2018 · 39 citations · Full text